Visual Acuity Testing (Snellen Chart)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Normal20/20–20/20
- Mild Impairment20/25–20/40
- Moderate Impairment20/50–20/100
- Severe Impairment20/125–20/200
The Visual Acuity Testing (Snellen Chart) calculates assessing binocular and monocular visual acuity using standardized Snellen optotypes. Key inputs include eye tested. Scores guide administering pressure-lowering ocular pharmacotherapy, urgent ophthalmologic surgical consult, and eye shielding. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Assesses binocular and monocular visual acuity using standardized Snellen optotypes. This test evaluates the clarity of vision by determining the smallest line of letters a patient can accurately read on a standardized chart at a specific distance. Visual acuity testing is a fundamental component of ophthalmologic and neurologic examinations, particularly for cranial nerve II (optic nerve) assessment.
Clinical Indication
The Visual Acuity Testing (Snellen Chart) is indicated for bedside clinical practice to support Assesses binocular and monocular visual acuity using standardized Snellen optotypes. This test evaluates the clarity of vision by determining the smallest line of letters a patient can accurately read on a standardized chart at a specific distance. Visual acuity testing is a fundamental component of ophthalmologic and neurologic examinations, particularly for cranial nerve II (optic nerve) assessment.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with ocular trauma, acute visual disturbance, acute angle-closure glaucoma, or retinal detachment. Clinical application is indicated across Eye emergency rooms, specialized ophthalmology clinics, and ocular trauma centers.
Limitations & Contraindications
In suspected open globe injury or penetrating ocular trauma, tonometry and any direct external pressure on the globe are contraindicated.
Clinical Pearls & Action Plan
Best-corrected visual acuity should be documented as an ocular vital sign before pharmacological dilation or intervention.
Visual acuity = Testing distance / Distance at which normal eye can read the same line. Standard notation: 20/X where X is the denominator corresponding to the smallest line read correctly.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| eye_tested | string | Yes | Which eye is being tested |
| lowest_line_read | string | Yes | The lowest (smallest) line that the patient can read correctly on the Snellen chart |
| testing_distance | string | Yes | Distance at which the test was performed |
| corrective_lenses | string | Yes | Whether the patient was wearing corrective lenses during testing |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 20/20–20/20 | Normal | Normal visual acuity |
| 20/25–20/40 | Mild Impairment | Mild visual impairment |
| 20/50–20/100 | Moderate Impairment | Moderate visual impairment |
| 20/125–20/200 | Severe Impairment | Severe visual impairment approaching legal blindness |
| CF–NLP | Profound Impairment | Profound visual impairment |
Evidence-Based References (EBM)
- Snellen H. Probebuchstaben zur Bestimmung der Sehschärfe. Utrecht: Van de Weijer; 1862.
- Elliott DB. The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement. Ophthalmic Physiol Opt. 2016;36(4):355-358. doi: 10.1111/opo.12310DOI: 10.1111/opo.12310
- Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5DOI: 10.1016/S2214-109X(17)30393-5
- Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53(11):740-745. doi: 10.1097/00006324-197611000-00006DOI: 10.1097/00006324-197611000-00006